![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
https://www.towayakuhin.co.jp/english/assets/info/pdf/release240315.pdf
https://www.towayakuhin.co.jp/english/assets/info/pdf/release240215.pdf
https://www.towayakuhin.co.jp/english/assets/info/pdf/release240214.pdf
https://www.biospectrumasia.com/news/25/20877/japan-approves-chugai-pharmas-osteoporosis-drug.html
https://en.prnasia.com/releases/apac/luye-pharma-and-towa-pharmaceutical-enter-strategic-collaboration-to-develop-and-commercialize-rivastigmine-multi-day-transdermal-patch-in-japan-308920.shtml
https://www.prnewswire.com/news-releases/towa-completes-acquisition-of-esteves-generic-division-300996882.html